“Has been a competent negotiating partner for many years”, competitor
As a lawyer specialising in pharmaceutical and IP law, Manja has been advising pharmaceutical and biotechnology companies, medical device manufacturers, and food producers on all matters relating to intellectual property and regulatory questions for many years.
A focus of her practice involves advising clients on contractual projects of a complex and cross-border nature, in particular, research and development cooperations, manufacturing agreements, distribution agreements, licencing agreements, as well as providing advise on all matters relating to transactions.
Überraschungsentscheidungen, in: GRUR-Prax 2024, together with Sherin Sayed
„Werbung für Arzneimittel“ auch bei Bezug zu unbestimmten Arzneimitteln gegeben, in: GRUR-Prax, 2023
Deutsche Vereinigung für gewerblichen Rechtsschutz und Urheberrecht
Fachausschuss für Arznei– und Lebensmittelrecht
Licensing Executives Society, Arbeitskreis Life Sciences
“Has been a competent negotiating partner for many years”, competitor
“A competent negotiating partner for many years", competitor
Leading individual for healthcare (pharmaceutical and medical products law)
Frequently recommended lawyer for healthcare - Hospitals, MVZs and pharmacies
Law firm of the year for IP Law
Recommended Lawyer: Germany - Life Sciences - Transactional
Thought Leader: Germany - Life Sciences
Recommended Lawyer: Germany - Life Sciences - Regulatory
Leading individual: Pharmaceuticals Law
Leading individual: Intellectual Property Law
Leading individual: Information Technology Law
Lawyer of the year: Biotechnology Law
Leading individual: Biotechnology Law
Ranked lawyer for Life Sciences
"She is very good and experienced."
Leading individual: Pharmaceutical and medical products law
Leading individual: Pharmaceuticals Law
Leading individual: Biotechnology Law and Life Sciences Practice
Leading individual: Information Technology Law
Leading individual: Intellectual Property Law
by multiple authors
Germany as a location for pharmaceutical businesses - quo vadis, 2024?
Strategy paper by the German Federal Government on improving the regulatory framework for the pharmaceutical industry in Germany
JUVE Awards 2023: Taylor Wessing named "Law Firm of the Year for IP”
by multiple authors
by multiple authors
by multiple authors
by multiple authors
by Alison Dennis and Alice Matthews
by Colin McCall and Charlie Adams
by multiple authors
by multiple authors
by multiple authors